(NVMI) Nova - Ratings and Ratios
Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0010845571
NVMI: Metrology, Systems, Instruments, Software, Hardware, Sensors
Nova Ltd. (NASDAQ:NVMI) is a leading provider of process control systems for the semiconductor manufacturing industry. Headquartered in Rehovot, Israel, the company operates globally, with a presence in key semiconductor hubs such as Taiwan, the United States, China, and Korea. Novas expertise lies in designing, developing, and selling metrology platforms that enable precise measurements of dimensional, films, materials, and chemical properties during various stages of semiconductor production. These measurements are critical for process control in steps like lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging.
The company serves a diverse range of customers within the integrated circuit manufacturing ecosystem, including logic manufacturers, foundries, memory producers, and process equipment suppliers. This broad customer base underscores Novas versatility and the critical role its solutions play in ensuring the quality and efficiency of semiconductor manufacturing processes. Nova Ltd., formerly known as Nova Measuring Instruments Ltd., rebranded in July 2021 to reflect its expanded scope and capabilities. Founded in 1993, the company has established itself as a trusted partner in the semiconductor industry, leveraging its deep technical expertise to deliver innovative metrology solutions.
From a financial perspective, Nova Ltd. has a market capitalization of approximately $7.8 billion, reflecting its significant presence in the industry. The companys trailing P/E ratio of 50.28 and forward P/E of 28.33 indicate investor confidence in its growth prospects. With a price-to-book ratio of 7.86 and a price-to-sales ratio of 12.77, Novas valuation metrics highlight its strong revenue generation and profitability. These figures are particularly relevant for investors and fund managers assessing the companys financial health and potential for future returns. For more information, visit their website at https://www.novami.com.
Additional Sources for NVMI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NVMI Stock Overview
Market Cap in USD | 6,416m |
Sector | Technology |
Industry | Semiconductor Equipment & Materials |
GiC Sub-Industry | Semiconductor Materials & Equipment |
IPO / Inception | 2000-04-07 |
NVMI Stock Ratings
Growth 5y | 77.0% |
Fundamental | 81.7% |
Dividend | 0.0% |
Rel. Strength | 5.2 |
Analysts | 4.43/5 |
Fair Price Momentum | 208.21 USD |
Fair Price DCF | 130.89 USD |
NVMI Dividends
No Dividends PaidNVMI Growth Ratios
Growth Correlation 3m | -18.5% |
Growth Correlation 12m | 31.5% |
Growth Correlation 5y | 84.1% |
CAGR 5y | 41.09% |
CAGR/Max DD 5y | 0.78 |
Sharpe Ratio 12m | 0.00 |
Alpha | -4.02 |
Beta | 1.455 |
Volatility | 55.56% |
Current Volume | 170k |
Average Volume 20d | 333.3k |
As of March 30, 2025, the stock is trading at USD 186.43 with a total of 170,027 shares traded.
Over the past week, the price has changed by -8.50%, over one month by -22.04%, over three months by -5.45% and over the past year by +4.68%.
Yes, based on ValueRay Fundamental Analyses, Nova (NASDAQ:NVMI) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 81.67 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVMI as of March 2025 is 208.21. This means that NVMI is currently undervalued and has a potential upside of +11.68% (Margin of Safety).
Nova has received a consensus analysts rating of 4.43. Therefor, it is recommend to buy NVMI.
- Strong Buy: 5
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, NVMI Nova will be worth about 238.5 in March 2026. The stock is currently trading at 186.43. This means that the stock has a potential upside of +27.9%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 283 | 51.8% |
Analysts Target Price | 236 | 26.6% |
ValueRay Target Price | 238.5 | 27.9% |